BAIYUNSHAN PH (00874.HK) Latest Stock News - Major News Analysis

Event Tracking

Dec1

Guangzhou Pharmaceutical Plans to Launch Accounts Receivable Securitization Business

10:47

Guang 白云山 Holds Q3 2025 Earnings Briefing

03:36

Nov28

Byhuan Mountain's Guanghua Pharmaceutical Launches Phase II Clinical Study on Pediatric Xiao Chaihu Granules for Gastrointestinal Flu

03:29

Nov19

Changsha Middle One Pharmaceutical Receives Vietnamese Registration Certificate for An Gong Niu Huang Wan

08:27

Oct28

BAIYUNSHAN PH released FY2025 Q3 earnings on October 28 After-Market (BJT), actual revenue HKD 21.61 B (forecast HKD 22.38 B), actual EPS HKD 0.5335

11:00

BAIYUNSHAN PH released FY2025 9 Months Earnings on October 28 After-Market (BJT), actual revenue HKD 66.87 B, actual EPS HKD 2.2011

11:00

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 21.61 B, Net Income 867.88 M, EPS 0.5335

Sep26

Distribution Plan(CST)

Cash dividend 0.4399 HKD

Sep1

Distribution Plan(CST)

Cash dividend 0.4399 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change